Institute of Biomedical and Clinical Science, Peninsula College of Medicine and Dentistry (University of Exeter), Tamar Science Park, Derriford, Plymouth, UK.
Diabetologia. 2010 Sep;53(9):2020-8. doi: 10.1007/s00125-010-1817-6. Epub 2010 Jun 9.
AIMS/HYPOTHESIS: In adults, the rate of beta cell replication is normally very low, but recent evidence suggests that it may increase during insulitis. We therefore studied tissue from donors with recent-onset type 1 diabetes to establish whether islet cell proliferation is increased during the disease process.
Paraffin-embedded pancreatic sections from ten donors with recent-onset type 1 diabetes and a range of relevant controls were stained by immunohistochemical techniques with antibodies against the proliferation markers Ki67 and minichromosome maintenance protein-2 (MCM-2). A combination staining technique involving immunoperoxidase and immunofluorescence methods was developed to quantify the numbers of alpha and beta cells with Ki67-positive nuclei and to investigate the relationship between insulitis and islet cell proliferation.
In non-diabetic control donors, only 1.1 +/- 0.3% (mean +/- SEM) of islets contained one or more Ki67(+) islet cells, whereas this proportion was increased markedly in recent-onset type 1 diabetes (10.88 +/- 2.5%; p < 0.005). An equivalent increase in Ki67(+) staining occurred in alpha and beta cells and was correlated positively with the presence of insulitis. A significant increase in the labelling of islet cells from type 1 diabetic donors was also seen when MCM-2 staining was employed. Increased islet cell proliferation was not evident in three donors with longer duration type 1 diabetes or in ten type 2 diabetic donors.
CONCLUSIONS/INTERPRETATION: Alpha and beta cells undergo a marked increase in proliferation during the progression of type 1 diabetes in humans. The results imply that islet cell proliferation is re-initiated in response to the autoimmune attack associated with type 1 diabetes.
目的/假设:在成年人中,β细胞的复制率通常非常低,但最近的证据表明,在胰岛炎期间它可能会增加。因此,我们研究了近期发生 1 型糖尿病供体的组织,以确定胰岛细胞增殖是否在疾病过程中增加。
使用免疫组织化学技术,用 Ki67 和微小染色体维持蛋白-2(MCM-2)的增殖标志物抗体对来自最近发生 1 型糖尿病的 10 名供体和一系列相关对照的石蜡包埋胰腺切片进行染色。开发了一种涉及免疫过氧化物酶和免疫荧光方法的组合染色技术,以定量具有 Ki67 阳性核的α和β细胞的数量,并研究胰岛炎与胰岛细胞增殖之间的关系。
在非糖尿病对照供体中,只有 1.1 +/- 0.3%(平均值 +/- SEM)的胰岛含有一个或多个 Ki67(+)胰岛细胞,而在近期发生的 1 型糖尿病中,这一比例明显增加(10.88 +/- 2.5%;p < 0.005)。Ki67(+)染色在α和β细胞中也发生了等效增加,并且与胰岛炎的存在呈正相关。在 10 名 2 型糖尿病供体中,也可以看到来自 1 型糖尿病供体的胰岛细胞标记物的显着增加。在病程较长的 3 名 1 型糖尿病患者或 10 名 2 型糖尿病患者中,并未发现胰岛细胞增殖增加。
结论/解释:在人类 1 型糖尿病的进展过程中,α和β细胞的增殖明显增加。结果表明,胰岛细胞增殖是对与 1 型糖尿病相关的自身免疫攻击的重新启动。